1. Home
  2. CYTK
  3. CYTK News

Latest Cytokinetics Incorporated (CYTK) News on March 26, 2025

Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last?
CYTK

Zacks

2 days ago

Cytokinetics (CYTK) Moves 5.4% Higher: Will This Strength Last?

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community
CYTK

GlobeNewswire

6 days ago

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

8 days ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK

MT Newswires

9 days ago

Cytokinetics Insider Sold Shares Worth $943,426, According to a Recent SEC Filing

CYTK

MT Newswires

9 days ago

UBS Lowers Price Target on Cytokinetics to $47 From $61, Maintains Neutral Rating

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo
CYTK

GlobeNewswire

9 days ago

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

CYTK

MT Newswires

21 days ago

Cytokinetics Insider Sold Shares Worth $1,080,750, According to a Recent SEC Filing

CYTK

MT Newswires

21 days ago

Cytokinetics Insider Sold Shares Worth $374,900, According to a Recent SEC Filing

Revenue Downgrade: Here's What Analysts Forecast For Cytokinetics, Incorporated (NASDAQ:CYTK)
CYTK

Simply Wall St.

21 days ago

Revenue Downgrade: Here's What Analysts Forecast For Cytokinetics, Incorporated (NASDAQ:CYTK)

CYTK

Argus Research

22 days ago

CYTK: Lowering target price to $35.00

Cytokinetics to Participate in March Investor Conferences
CYTK

GlobeNewswire

23 days ago

Cytokinetics to Participate in March Investor Conferences

Cytokinetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
CYTK

Simply Wall St.

25 days ago

Cytokinetics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Cytokinetics Q4 Loss Wider Than Expected, Aficamten in Focus
CYTK

Zacks

a month ago

Cytokinetics Q4 Loss Wider Than Expected, Aficamten in Focus

CYTK

Thomson Reuters StreetEvents

a month ago

Q4 2024 Cytokinetics Inc Earnings Call

CYTK

MT Newswires

a month ago

Oppenheimer Adjusts Price Target on Cytokinetics to $96 From $98, Maintains Outperform Rating

Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses
CYTK

GuruFocus.com

a month ago

Cytokinetics Inc (CYTK) Q4 2024 Earnings Call Highlights: Revenue Surge Amidst Rising Expenses

Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
CYTK

Zacks

a month ago

Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates

CYTK

Associated Press Finance

a month ago

Cytokinetics: Q4 Earnings Snapshot

CYTK

MT Newswires

a month ago

Cytokinetics Q4 Net Loss Narrows, Revenue Rises

Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update
CYTK

GlobeNewswire

a month ago

Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update

Cytokinetics Inc (CYTK) Q4 2024: Everything You Need To Know Ahead Of Earnings
CYTK

GuruFocus.com

a month ago

Cytokinetics Inc (CYTK) Q4 2024: Everything You Need To Know Ahead Of Earnings

CYTK

Argus Research

a month ago

CYTK: Raising target price to $37.00

Cytokinetics, Incorporated (CYTK): the Most Oversold Pharma Stock to Buy According to Analysts
CYTK

Insider Monkey

a month ago

Cytokinetics, Incorporated (CYTK): the Most Oversold Pharma Stock to Buy According to Analysts

Cytokinetics, Incorporated (CYTK): One of the Most Oversold Healthcare Stocks to Buy Now
CYTK

Insider Monkey

a month ago

Cytokinetics, Incorporated (CYTK): One of the Most Oversold Healthcare Stocks to Buy Now

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
CYTK

Zacks

a month ago

Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

a month ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK

Argus Research

a month ago

CYTK: Raising target price to $36.00

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025
CYTK

GlobeNewswire

a month ago

Cytokinetics to Announce Fourth Quarter Results on February 27, 2025

CYTK

MT Newswires

a month ago

Morgan Stanley Upgrades Cytokinetics to Overweight From Equalweight, Adjusts Price Target to $67 From $70

CYTK

MT Newswires

a month ago

Morgan Stanley Upgrades Cytokinetics to Overweight From Equalweight, Trims Price Target to $67 From $70

Cytokinetics Names Robert E. Landry to Board of Directors
CYTK

GlobeNewswire

a month ago

Cytokinetics Names Robert E. Landry to Board of Directors

Why Cytokinetics, Incorporated (CYTK) Is Among the Best Healthcare Stocks To Buy According to Analysts
CYTK

Insider Monkey

2 months ago

Why Cytokinetics, Incorporated (CYTK) Is Among the Best Healthcare Stocks To Buy According to Analysts

CYTK

MT Newswires

2 months ago

Citigroup Initiates Cytokinetics at Buy With $86 Price Target

Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
CYTK

GlobeNewswire

2 months ago

Cytokinetics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

CYTK

MT Newswires

2 months ago

B. Riley Adjusts Cytokinetics' Price Target to $88 From $92, Keeps Buy Rating

CYTK

Argus Research

2 months ago

CYTK: What does Argus have to say about CYTK?

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics
CYTK

Zacks

2 months ago

The Zacks Analyst Blog Highlights Sage Therapeutics, Biogen, Cytokinetics and Akero Therapeutics

Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates
CYTK

Zacks

2 months ago

Biotech Stock Roundup: SAGE Up on Declining BIIB's Offer, CYTK, AKRO Up on Updates

CYTK

Argus Research

2 months ago

CYTK: Raising target price to $39.00

What Are Analysts Talking About Cytokinetics (CYTK)?
CYTK

Insider Monkey

2 months ago

What Are Analysts Talking About Cytokinetics (CYTK)?

CYTK Stock Rises as Enrollment Begins in Phase II Heart Failure Study
CYTK

Zacks

2 months ago

CYTK Stock Rises as Enrollment Begins in Phase II Heart Failure Study

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
CYTK

Benzinga

2 months ago

Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst

CYTK

Argus Research

2 months ago

CYTK: Raising target price to $37.00

Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces Start of AMBER-HFpEF, a Phase 2 Clinical Trial of CK-586 in Patients With Symptomatic Heart Failure With Preserved Ejection Fraction

CYTK

Argus Research

2 months ago

CYTK: Lowering target price to $36.00

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
CYTK

GlobeNewswire

2 months ago

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CYTK

GlobeNewswire

3 months ago

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

CYTK

Argus Research

3 months ago

CYTK: Raising target price to $51.00

CYTK

MT Newswires

3 months ago

Cytokinetics Says European Regulator Validated its Application for Cardiomyopathy Drug Candidate

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Why Cytokinetics Stock Was a Nearly 5% Winner Today
CYTK

Motley Fool

3 months ago

Why Cytokinetics Stock Was a Nearly 5% Winner Today

CYTK

MT Newswires

3 months ago

Cytokinetics Says Sanofi Acquiring Rights for Aficamten in Greater China

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
CYTK

GlobeNewswire

3 months ago

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China

Calculating The Fair Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)
CYTK

Simply Wall St.

3 months ago

Calculating The Fair Value Of Cytokinetics, Incorporated (NASDAQ:CYTK)

CYTK

MT Newswires

3 months ago

RBC Raises Price Target on Cytokinetics to $82 From $80, Keeps Outperform, Speculative Risk

CYTK

Argus Research

3 months ago

CYTK: Lowering target price to $50.00

CYTK

Argus Research

4 months ago

CYTK: Rating increased to a HOLD

CYTK

MT Newswires

4 months ago

Cytokinetics Insider Sold Shares Worth $369,639, According to a Recent SEC Filing

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?
CYTK

Zacks

4 months ago

Why Is Cytokinetics (CYTK) Down 9.7% Since Last Earnings Report?

Cytokinetics Initiates Confirmatory Study on Heart Failure Drug
CYTK

Zacks

4 months ago

Cytokinetics Initiates Confirmatory Study on Heart Failure Drug

CYTK

Argus Research

4 months ago

CYTK: Lowering target price to $41.00

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CYTK

MT Newswires

4 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

FDA Accepts Cytokinetics' Application for Cardiovascular Drug
CYTK

Zacks

4 months ago

FDA Accepts Cytokinetics' Application for Cardiovascular Drug

CYTK

MT Newswires

4 months ago

Cytokinetics Begins Phase 3 Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Start of COMET-HF, a Confirmatory Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

Cytokinetics to Participate in December Investor Conferences
CYTK

GlobeNewswire

4 months ago

Cytokinetics to Participate in December Investor Conferences

CYTK

MT Newswires

4 months ago

Cytokinetics Says US FDA Accepts New Drug Application for Aficamten to Treat Obstructive Hypertrophic Cardiomyopathy

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date
CYTK

BioPharma Dive

4 months ago

Novocure device succeeds in pancreatic cancer study; FDA sets Cytokinetics decision date

Cytokinetics price target raised to $103 from $99 at Mizuho
CYTK

TipRanks

4 months ago

Cytokinetics price target raised to $103 from $99 at Mizuho

Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?
CYTK

Insider Monkey

4 months ago

Why Is Cytokinetics, Incorporated (CYTK) Among the Worst Performing Biotech Stocks in 2024?

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
CYTK

Zacks

4 months ago

Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan

Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
CYTK

BioPharma Dive

4 months ago

Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer

CYTK

MT Newswires

4 months ago

Cytokinetics, Bayer Partner to Develop, Commercialize Potential Cardiomyopathy Treatment in Japan

Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan
CYTK

GuruFocus.com

4 months ago

Cytokinetics Will Get More Revenue for Marketing Aficamten in Japan

Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan
CYTK

GuruFocus.com

4 months ago

Cytokinetics and Bayer Partner to Expand Aficamten's Reach in Japan

Bayer acquires rights to Cytokinetics' heart drug in Japan
CYTK

Reuters

4 months ago

Bayer acquires rights to Cytokinetics' heart drug in Japan

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan
CYTK

GlobeNewswire

4 months ago

Cytokinetics and Bayer Announce Exclusive Licensing Collaboration for Aficamten in Japan

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024
CYTK

GlobeNewswire

4 months ago

Cytokinetics Presents Additional Data From GALACTIC-HF at the American Heart Association Scientific Sessions 2024

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024
CYTK

GlobeNewswire

4 months ago

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

CYTK

MT Newswires

4 months ago

Cytokinetics Insider Sold Shares Worth $370,880, According to a Recent SEC Filing

CYTK

Argus Research

4 months ago

CYTK: Raising target price to $45.00

Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference
CYTK

GlobeNewswire

4 months ago

Cytokinetics to Participate in the 2024 Jefferies London Healthcare Conference

CYTK

MT Newswires

4 months ago

Cytokinetics Doses First Participants in Study of Potential Muscular Dystrophy Treatment

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
CYTK

GlobeNewswire

4 months ago

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089

CYTK

MT Newswires

5 months ago

RBC Starts Cytokinetics With Outperform Rating, $80 Price Target

Cytokinetics Third Quarter 2024 Earnings: Misses Expectations
CYTK

Simply Wall St.

5 months ago

Cytokinetics Third Quarter 2024 Earnings: Misses Expectations

CYTK

MT Newswires

5 months ago

Cytokinetics Q3 Loss Widens, Revenue Rises

Cytokinetics Inc (CYTK) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
CYTK

GuruFocus.com

5 months ago

Cytokinetics Inc (CYTK) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates
CYTK

Zacks

5 months ago

Cytokinetics (CYTK) Reports Q3 Loss, Lags Revenue Estimates

CYTK

Associated Press Finance

5 months ago

Cytokinetics: Q3 Earnings Snapshot

Cytokinetics Reports Third Quarter 2024 Financial Results
CYTK

GlobeNewswire

5 months ago

Cytokinetics Reports Third Quarter 2024 Financial Results

CYTK

Argus Research

5 months ago

CYTK: Raising target price to $42.00

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024
CYTK

GlobeNewswire

5 months ago

Cytokinetics Announces Six Upcoming Presentations at the American Heart Association Scientific Sessions 2024

Earnings To Watch: Cytokinetics Inc (CYTK) Reports Q3 2024 Result
CYTK

GuruFocus.com

5 months ago

Earnings To Watch: Cytokinetics Inc (CYTK) Reports Q3 2024 Result

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CYTK

GlobeNewswire

5 months ago

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share on Social Networks: